PRNewswire

Sen-Jam Pharmaceutical has entered their third development, manufacturing, distribution and license agreement with KVK-Tech. This is a monumental milestone for the company and great news for their promising multi-use anti-inflammatory injectable. HUNTINGTON, N.Y., April 10, 2024 /PRNewswire/ —

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: